Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

X-Rite Agrees To Be Acquired By Danaher In $478 Million Deal

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/10/2012 | 02:45pm CET

Color-measurement technology company X-Rite Inc. (XRIT) agreed to be acquired by diversified manufacturer Danaher Corp. (>> Danaher Corporation) in a deal valued at $478 million.

The $5.55-a-share offer represents a 39% premium to Monday's closing price. X-Rite shares closed Monday at $4 each and were halted in recent premarket trading. The stock is down 14% this year.

X-Rite Chief Executive Thomas J. Vacchiano Jr. said that joining Danaher will give the company--known for Pantone color matching system--resources to achieve its growth goals, expanded access to new market and complementary technologies.

After the deal closes, anticipated in the current quarter, X-Rite will operate as a standalone unit in Danaher's product identification group and existing management will remain in senior leadership positions.

Danaher expects the acquisition will complement its Esko digital packaging design capabilities and further its leading position in the product identification industry. The diversified toolmaker has been relying on acquisitions to bolster a slow-growing revenue base.

Including debt assumption and net of cash, the deal is valued at a total of $625 million.

Danaher shares closed Monday at $54.59 and were inactive in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Danaher Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER CORPORATION
01/11 DANAHER : Schedules Fourth Quarter 2016 Earnings Conference Call
01/11 DANAHER CORPORATION (NASDAQ : DHR) Files An 8-K Results of Operations and Financ..
01/10 DANAHER CORPORATION (NYSE : DHR) Files An 8-K Results of Operations and Financia..
01/10 DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
01/04 DANAHER : To Present At J.P. Morgan Healthcare Conference
2016 DANAHER CORPORATION : ex-dividend day
2016 DANAHER : Initiates 2017 Outlook
2016 DANAHER CORPORATION : Declares Dividend of $0.1250.
2016 DANAHER CORP /DE/ : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Y..
2016 DANAHER : Announces Quarterly Dividend
More news
Sector news : Advanced Medical Equipment & Technology - NEC
11:51a PHILIPS LIGHTING : misses on fourth quarter, sees growth in 2017
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/13 Pentair, Roper upgraded at J.P. Morgan on Trump effect; GE a "top avoid"
01/11 Medtech Mergers And Acquisitions Regresses To The Mean In 2016
01/11 Danaher Corporation (DHR) presents at 35th Annual J.P. Morgan Healthcare Conf..
01/04 Political Ructions, Poor Deal-Making And Scandal - A Bad Year For Big-Cap Med..
2016 ESCO Technologies - A Tough Mix Of Potential And Past Performance
Advertisement
Financials ($)
Sales 2016 16 839 M
EBIT 2016 2 990 M
Net income 2016 2 250 M
Debt 2016 9 975 M
Yield 2016 0,72%
P/E ratio 2016 26,84
P/E ratio 2017 25,00
EV / Sales 2016 3,90x
EV / Sales 2017 3,51x
Capitalization 55 703 M
More Financials
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 89,3 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION3.46%55 703
THERMO FISHER SCIENTIF..1.71%56 690
BOSTON SCIENTIFIC CORP..10.49%32 544
PHILIPS-3.72%27 770
INTUITIVE SURGICAL, IN..3.56%25 447
ILLUMINA, INC.24.76%23 466
More Results